Advertisement

The relationship of Alzheimer-type pathology to dementia in Parkinson’s disease

  • K. Jendroska
Conference paper

Summary

Lewy body degeneration of the subcortical nuclei other than the substantia nigra is common in PD and may represent the substrate for a higher vulnerability to dementia in patients with PD. Cortical pathologies of Alzheimer and Lewy body type seem to be the major determinants of dementia. The prevalence of Alzheimer’s disease is not increased in PD, but “early” cortical Alzheimer lesions (usually sub-clinical in normal controls) are frequently associated with dementia in PD. Furthermore, dementia in PD is heterogeneous and should always prompt the clinician to search for treatable causes.

Keywords

Multiple System Atrophy Lewy Body Alzheimer Pathology Normal Pressure Hydrocephalus Subcortical Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agid Y, Ruberg M, Raisman R, et al (1990) The biochemistry of Parkinson’s disease. In: Stern G (ed) Parkinson’s disease. Chapman and Hall Medical, LondonGoogle Scholar
  2. Alvord EC, Forno LS, Kusske JA, et al (1974) The pathology of Parkinsonism: a comparison of degeneration in cerebral cortex and brainstem. Adv Neurol 5: 175–193PubMedGoogle Scholar
  3. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr 64: 146–148Google Scholar
  4. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans, and Korsakoff’s disease. Acta Neuropathol 61: 101–108PubMedCrossRefGoogle Scholar
  5. Ball MJ (1984) The morphological basis of dementia in Parkinson’s disease. Can J Neurol Sci 11: 180–184PubMedGoogle Scholar
  6. Boller F (1985) Parkinson’s disease and Alzheimer’s disease. Are they associated? In: Hutton JT, Kenny AD (eds) Senile dementia of the Alzheimer type, vol 18. Liss, New YorkGoogle Scholar
  7. Boller F, Mitzutani T, Roessman U, et al (1980) Parkinson disease, dementia and Alzheimer disease: clinicopathological correlations. Ann Neurol 7: 329–335PubMedCrossRefGoogle Scholar
  8. Bonaiuto S, Rocca W, Lippi A, et al (1990) Impact of education and occupation on the prevalence of Alzheimer’s disease (AD) and multi-infarct-dementia (MID) in Appignano, Macerata Province, Italy. Neurology 40 [Suppl 1]: 346 (Abstract)Google Scholar
  9. Braak H, Braak E (1990) Cognitive impairment in Parkinson’s disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm [P-D Sect] 2: 45–57CrossRefGoogle Scholar
  10. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239–259PubMedCrossRefGoogle Scholar
  11. Brown RG, Marsden CD (1984) How common is dementia in Parkinson’s disease? Lancet 2: 1262–1265PubMedCrossRefGoogle Scholar
  12. Brown RG, Marsden CD (1990) Cognitive function in Parkinson’s disease: from description to theory. TINS 13: 21–29PubMedGoogle Scholar
  13. Candy JM, Perry RH, Perry EK, et al (1983) Pathological changes in the nucleus basalis of Meynert in Alzheimer’s and Parkinson’s disease. J Neurol Sci 59: 277–289PubMedCrossRefGoogle Scholar
  14. Chan-Palay V, Asan E (1989) Alterations in catecholamin neurons in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287: 373–392PubMedCrossRefGoogle Scholar
  15. Chartier-Harlin MC, Crawford F, Houlden H, et al (1991) Earlyonset Alzheimer’s disease caused by mutations at codon 717 of the ß-amyloid precursor protein gene. Nature 353: 844–846PubMedCrossRefGoogle Scholar
  16. Cochran E, Bacci B, Chen Y, et al (1991) Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer’s disease. Am J Pathol 139: 485–489PubMedGoogle Scholar
  17. Critchley M (1931) The neurology of old age. Lancet ii: 1119–1127CrossRefGoogle Scholar
  18. Crystal H, Dickson D, Fuld P (1988) Clinico-pathologic studies in dementia: non-demented subjects with pathologically confirmed Alzheimer’s disease. Neurology 38: 1682–1687PubMedGoogle Scholar
  19. Davies L, Wolska B, Hilbich H, et al (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathological techniques. Neurology 38: 1688–1693PubMedGoogle Scholar
  20. Dickson DW, Singer G, Davies P, et al (1993) Regional immunocytochemical studies of brains of prospectively studied demented and nondemented normal elderly humans. In: Nicolini M, Zatta PF, Corain B (eds) Alzheimer’s disease and related disorders. Advances in the biosciences, vol 87. Pergamon Press, OxfordGoogle Scholar
  21. Ditter SM, Mirra SS (1987) Neuropathology and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Neurology 37: 754–760PubMedGoogle Scholar
  22. Duyckaerts C, Gaspar P, Costa C, et al (1993) Dementia in Parkinson’s disease: morphometry data. Adv Neurol 60: 442–455Google Scholar
  23. Flood JF, Roberts E, Sherman MA, et al (1994) Topography of a binding site for small amnestic peptides deduced from structureactivity studies: relation to amnestic effect of amyloid protein. Proc Natl Acad Sci USA 91: 380–384PubMedCrossRefGoogle Scholar
  24. Gaspar P, Gray F (1984) Dementia in idiopathic Parkinson’s disease. A neuropathological study of 32 cases. Acta Neuropathol 64: 43–52PubMedCrossRefGoogle Scholar
  25. Gibb WRG (1989) Dementia and Parkinson’s disease. Br J Psychiatry 154: 492–497CrossRefGoogle Scholar
  26. Gibb WRG, Lees AJ (1988) A comparison of clinical and pathological features of young and old-onset Parkinson’s disease. Neurology 38: 1402–1406PubMedGoogle Scholar
  27. Glenner GG, Wong CW (1984) Initial report on the purification and characterisation of a novel cerebro-vascular amyloid protein. Biochem Biophys Res Commun 120: 885–890PubMedCrossRefGoogle Scholar
  28. Goate A, Chartier-Harlin MC, Mullan M, et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706PubMedCrossRefGoogle Scholar
  29. Hakim AM, Mathieson G (1979) Dementia in Parkinson’s disease. A neuropathological study. Neurology 29: 1209–1214PubMedGoogle Scholar
  30. Heilig CW, Knopman DS, Mastri AR, Frey W (1985) Dementia without Alzheimer pathology. Neurology 35: 762–765PubMedGoogle Scholar
  31. Hendriks L, van Duijn CM, Cras P, et al (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the ß-amyloid precursor protein gene. Nature Genet 1: 218–221PubMedCrossRefGoogle Scholar
  32. Jellinger K (1989) Pathology of Parkinson’s syndrome. In: Calne DB (ed) Handbook of experimental pharmacology, vol 88. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  33. Jendroska K, Poewe W, Daniel SE, et al (1995) Ischemic stress induces deposition of amyloid ß-immunoreactivity in human brain. Acta Neuropathol 5: 461–466CrossRefGoogle Scholar
  34. Jendroska K, Poewe W, Lees AJ, Daniel SE (1996) Amyloid ß-peptide and the dementia of Parkinson’s disease. Mov Disord 11: 647–653PubMedCrossRefGoogle Scholar
  35. Jorm AF, Henderson AS, Jacomb PA (1988) Projected increases in the number of dementia cases for 29 developed countries: application of a new method for making projections. Acta Psychiatr Scand 78: 493–500PubMedCrossRefGoogle Scholar
  36. Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1105PubMedGoogle Scholar
  37. Lees AJ (1985) Parkinson’s disease and dementia. Lancet i: 43–44CrossRefGoogle Scholar
  38. Leverenz S, Sumi SM (1986) Parkinson’s disease in patients with Alzheimer’s disease. Arch Neurol 43: 662–664PubMedGoogle Scholar
  39. Lewy FH (1913) Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilk 50: 50–55Google Scholar
  40. Lewy FH (1923) Die Lehre vom Tonus und der Bewegung. Zugleich eine systematische Untersuchung zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis agitans. Springer, BerlinGoogle Scholar
  41. Lima B, Neves B, Nora M (1987) Juvenile parkinsonism: clinical and metabolic characteristics. J Neurol Neurosurg Psychiatry 50: 345–348PubMedCrossRefGoogle Scholar
  42. Mann DMA, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson’s disease. Neuropathol Appl Neurobiol 9: 3–19PubMedCrossRefGoogle Scholar
  43. Martin WE, Loewenson RB, Resch JA, Baker AB (1973) Parkinson’s disease. A clinical analysis of 100 patients. Neurology 23: 783–790PubMedGoogle Scholar
  44. Masters CL, Simms G, Weinmann NA, et al (1985) Amyloid plaque core protein in Alzheimer’s disease and Down’s syndrome. Proc Natl Acad Sci USA 82: 4245–4259PubMedCrossRefGoogle Scholar
  45. Mayeux R, Denaro J, Hemenegilde N, et al (1992) A populationbased investigation of Parkinson’s disease with and without dementia. Arch Neurol 49: 492–497PubMedGoogle Scholar
  46. Mirra SS, Heyman A, McKeel D, et al (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD), part II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41: 479–86PubMedGoogle Scholar
  47. Mullan M, Crawford F, Axelman K, et al (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of ß-amyloid. Nature Genet 1: 345–47PubMedCrossRefGoogle Scholar
  48. Murrell J, Farlow M, Ghetti B, Benson M (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99PubMedCrossRefGoogle Scholar
  49. Nakano I, Jirano A (1984) Parkinson’s disease: neuron loss in the nucleus basalis without concomitant Alzheimer’s disease. Ann Neurol 15: 415–418PubMedCrossRefGoogle Scholar
  50. Patrick HT, Levy DM (1922) Parkinson’s disease: a clinical study of 106 cases. Arch Neurol Psychiatry 7: 711–720Google Scholar
  51. Paulus W, Jellinger K (1991) The neuropathological basis of different clinical subgroups of Parkinson’s disease. Neuropathol Exp Neurol 50: 743–755CrossRefGoogle Scholar
  52. Pendlebury WW, Perl DP (1984) Nucleus basalis of Meynert. Severe cell loss in Parkinson’s disease without dementia. Ann Neurol 16: 129 (Abstract)Google Scholar
  53. Quinn NP, Rossor MN, Marsden CD (1986) Dementia and Parkinson’s disease - pathological and neurochemical considerations. Br Med Bull 42: 86–90PubMedGoogle Scholar
  54. Quinn NP, Rossor MN, Marsden CD (1987) Young onset Parkinson’s disease. Mov Disord 2: 73–91PubMedCrossRefGoogle Scholar
  55. Roberts GW, Gentleman SM, Lynch A, et al (1991) ßA4-amyloid protein deposition in brain after head trauma. Lancet 338: 1422–1423PubMedCrossRefGoogle Scholar
  56. Sola C, Garcia-Ladona FJ, Mengod G, et al (1993) Increased levels of the Kunitz protease inhibitor—containing ßAPP mRNAs in rat brain following neurotoxic damage. Mol Brain Res 17: 41–52PubMedCrossRefGoogle Scholar
  57. Tagliavini F, Pilleri G, Bouras C, Constantinidis J (1984) The basal nucleus of Meynert in idiopathic Parkinson’s disease. Acta Neurol Scand 69: 20–28CrossRefGoogle Scholar
  58. Taraboulos A, Jendroska K, DeArmond SJ, et al (1992) Mapping of prion proteins in brain. Proc Natl Acad Sci USA 89: 7620–7624PubMedCrossRefGoogle Scholar
  59. Terry RD, Masliah E, Salmon DP, et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572–580PubMedCrossRefGoogle Scholar
  60. Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7: 331–356PubMedCrossRefGoogle Scholar
  61. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205–242PubMedCrossRefGoogle Scholar
  62. Van Nostrand WE, Wagner SL, Suzuki M, et al (1989) Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid ß-protein precursor. Nature 341: 546–549PubMedCrossRefGoogle Scholar
  63. Whitehouse PJ, Hedreen JC, White CL, Price DL (1983) Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 13: 243–248PubMedCrossRefGoogle Scholar
  64. Yankner BA, Dawes LR, Fisher S, et al (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science 245: 417–420PubMedCrossRefGoogle Scholar
  65. Zhan SS, Beyreuther K, Schmitt HP (1992) Synaptophysin expressivity of the cortical neuropil in primary neurodegenerative and vascular dementia. Neurobiol Aging 13: 41 (Abstract)Google Scholar
  66. Zhang M, Katzman R, Salmon D, et al (1990) The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender and education. Ann Neurol 27: 428–437PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • K. Jendroska
    • 1
  1. 1.Department of NeurologyUniversity Clinic CharitéBerlinGermany

Personalised recommendations